Acute Myeloid Leukemia (AML) Market is segmented By Therapy (Chemotherapy, Targeted Therapy, Immunotherapy), By Route of Administration (Oral, Intravenous), By End User (Hospitals, Specialty Clinics), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned segments.